2023 Best of Lung: Targeted Therapies in Lung Cancer

Поделиться
HTML-код
  • Опубликовано: 5 окт 2023
  • In this session from the Total Health 2023 Best of Lung conference, Dr Jaime Schneider from Massachusetts General Hospital Cancer Center discusses the use of targeted treatments in lung cancer.
  • РазвлеченияРазвлечения

Комментарии • 8

  • @prajapatiparth3685
    @prajapatiparth3685 4 дня назад

    In ros 1 nsclc which medicine is best crizotinib or ceritinib?

  • @ashutoshvyas885
    @ashutoshvyas885 4 месяца назад +2

    Squamous cell carcinoma alk positive cancer me best ky h

    • @rajib17cmc
      @rajib17cmc 4 месяца назад

      ALK positive is very rare in squamous cell carcinoma. But may happen in females and non smokers.
      Best treatment is a group of drug called ALK TKI. Lorlatinib, Alectinib are the best among them.

  • @susancrounse7030
    @susancrounse7030 3 месяца назад

    So with squamous nsclc my best bet after radiation,chemo,and immuni therapy is I’m still looking at a year at best

    • @gygi3490
      @gygi3490 3 месяца назад

      So live that year to the best!

    • @gygi3490
      @gygi3490 3 месяца назад +1

      So live that year to the best

  • @kathb1683
    @kathb1683 4 месяца назад

    TKI side effects?!